← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksYDESPrice History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

YDES logoYD Bio Limited Ordinary Shares (YDES) Stock Price History

Historical prices from 2025 to 2026

Current Price
$8.45
-0.02 (-0.24%)
All-Time High
$25.00
Sep 12, 2025
-66.2% from ATH
All-Time Low
$5.30
Aug 28, 2025
Avg Volume (50D)
40K
Daily average
52-Week Range$5.30 — $25.00
LowCurrent: $8.45High

Loading 10-year price history...

Historical Performance

1 YearTotal Return
-29.8%
Price: -29.8%
3 YearsTotal Return
-29.8%
CAGR: -11.1%
Price: -29.8%
5 YearsTotal Return
-29.8%
CAGR: -6.8%
Price: -29.8%
YTD
-29.6%

Short-Term Returns

1D-2.9%
1W-6.4%
1M-21.5%
3M-39.2%
6M-45.8%

Download Historical Data

142 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

YDES Stock Price Trajectory (2025–2026)

As of March 5, 2026, YD Bio Limited Ordinary Shares (YDES) trades at $8.45, representing a -29.8% return over the past year. The stock has delivered a -6.8% return over five years, reflecting challenging market conditions.

The stock reached its all-time high of $25.00 on September 12, 2025. From this peak, YDES has corrected -66.2%.

When compared to Healthcare sector peers CAI (-29.1% 1Y), VCYT (+10.0% 1Y), and ADPT (+104.7% 1Y), YDES has underperformed the peer group average. Compare YDES vs CAI →

Historical Price Data

Showing 30 of 142 records
Date Open High Low Close Volume Change %
2026-03-048.668.668.408.458K-0.24%
2026-03-038.648.808.478.473K-2.64%
2026-03-028.589.288.588.7014K+1.40%
2026-02-279.469.468.588.5813K-4.98%
2026-02-268.409.248.409.0311K+7.12%
2026-02-258.218.508.218.4311K+4.59%
2026-02-248.488.498.028.066K-0.86%
2026-02-238.038.878.008.1319K+1.35%
2026-02-208.808.978.028.028-8.84%
2026-02-198.568.958.408.8013K+3.26%
2026-02-188.759.208.408.5219K-10.86%
2026-02-179.849.879.569.563K-2.85%
2026-02-1310.3110.319.819.849K+0.31%
2026-02-1211.2011.279.769.8154K-11.22%
2026-02-1111.0311.2910.9011.059K-1.34%
2026-02-1011.3311.4911.0511.2023K-1.15%
2026-02-0911.5411.8010.8111.3335K+0.44%
2026-02-0611.2211.7811.0111.2838K+4.83%
2026-02-0511.1311.1510.6610.7638K-3.32%
2026-02-0410.8511.4010.5611.1355K+2.58%
2026-02-0311.7611.8310.8510.8555K-5.41%
2026-02-0211.6512.0011.3011.4743K-3.37%
2026-01-3011.0311.8711.0311.8735K+7.62%
2026-01-2912.3012.3011.0311.0358K-9.89%
2026-01-2812.0012.3012.0012.2413K+0.66%
2026-01-2711.9812.3511.8012.1633K+1.12%
2026-01-2612.3912.3911.7412.0318K-2.71%
2026-01-2412.3312.4912.1012.368K0.00%
2026-01-2312.3312.5011.9712.3612K+0.49%
2026-01-2212.0012.4911.5312.3062K+2.50%

See YDES's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is YDES Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare YDES vs LLY

See how YDES stacks up against sector leader Eli Lilly and Company.

Start Comparison

Frequently Asked Questions

How has YDES stock performed recently?

YDES declined -29.8% over the past year, below its 5-year annualized CAGR of -6.8%. The stock trades near its 200-day moving average, reflecting the downtrend.

What is YDES's all-time high price?

YD Bio Limited Ordinary Shares reached $25.00 on 2025-09-12. The 52-week high is $25.00. Current 1-year return of -29.8% places the stock further from historical peaks.

Where can I download YDES historical price data?

This page provides YDES daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2025-2026, downloadable in CSV format.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.
Showing 142 data points